Suchergebnis | Hamburg Open Science

Facetten

59 Einträge gefunden

Osteoprotection in the management of metastatic prostate cancer: real-world data from Germany and decision guidance, Osteoprotektion als Baustein der Therapie des metastasierten Prostatakarzinoms: Behandlungsrealität in Deutschland und Entscheidungspfade zur Therapieoptimierung
2022 - Forschungsinformationssystem des UKE
CARD study:relevance for the treatment of advanced prostate cancer, CARD-Studie – Bedeutung für die Therapie des fortgeschrittenen Prostatakarzinoms
2020 - Forschungsinformationssystem des UKE
Viele innovative Substanzen: Kastrationsresistentes fortgeschrittenes Prostatakarzinom
2015 - Forschungsinformationssystem des UKE
Moderne Systemtherapie des fortgeschrittenen Prostatakarzinoms
2014 - Forschungsinformationssystem des UKE
Current treatment concepts for castration resistant prostate cancer, Aktuelle Therapiekonzepte bei kastrationsresistenten Prostatakarzinom
2014 - Forschungsinformationssystem des UKE
Circulating miRNAs are correlated with tumor progression in prostate cancer.
2011 - Forschungsinformationssystem des UKE
[Type and extent of preoperative imaging before radical prostatectomy].
2010 - Forschungsinformationssystem des UKE
The presence of prostate cancer on saturation biopsy can be accurately predicted.
2010 - Forschungsinformationssystem des UKE
The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy.
2010 - Forschungsinformationssystem des UKE
Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage.
2010 - Forschungsinformationssystem des UKE
Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer.
2010 - Forschungsinformationssystem des UKE
External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series.
2009 - Forschungsinformationssystem des UKE
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer.
2009 - Forschungsinformationssystem des UKE
Partin Tables cannot accurately predict the pathological stage at radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Prostate cancer in the elderly.
1. Heinzer, Hans
2. Steuber, Thomas
2009 - Forschungsinformationssystem des UKE
Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.
2009 - Forschungsinformationssystem des UKE
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.
2009 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Osteoprotection in the management of metastatic prostate cancer: real-world data from Germany and decision guidance, Osteoprotektion als Baustein der Therapie des metastasierten Prostatakarzinoms: Behandlungsrealität in Deutschland und Entscheidungspfade zur Therapieoptimierung

CARD study:relevance for the treatment of advanced prostate cancer, CARD-Studie – Bedeutung für die Therapie des fortgeschrittenen Prostatakarzinoms

Viele innovative Substanzen: Kastrationsresistentes fortgeschrittenes Prostatakarzinom

Moderne Systemtherapie des fortgeschrittenen Prostatakarzinoms

Current treatment concepts for castration resistant prostate cancer, Aktuelle Therapiekonzepte bei kastrationsresistenten Prostatakarzinom

Circulating miRNAs are correlated with tumor progression in prostate cancer.

[Type and extent of preoperative imaging before radical prostatectomy].

The presence of prostate cancer on saturation biopsy can be accurately predicted.

The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy.

Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage.

Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer.

External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy.

Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series.

Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer.

Partin Tables cannot accurately predict the pathological stage at radical prostatectomy.

Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.

Prostate cancer in the elderly.

Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.

Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.

Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.